Providing market intelligence for more than 35 years

In The News

Deeper Dive—Who would buy DirecTV?

Although DirecTV is losing subscribers at a rapid pace, it’s not exactly a lost cause. Brett Sappington, senior research director and principal analyst at Parks Associates, said the satellite operator still has approximately 19 million subscribers and another incremental 13.5 million video subscribers in Latin America. It’s just a case of finding a strategic alignment with a potential acquisition partner.

“Good potential acquisition partners would be companies wanting to either establish a video service foothold in the Americas or to expand their current holdings in these markets,” said Sappington in an email. “Altice is an example of a European company that bought its way into the Americas through acquisition. Other global providers might consider the same approach.”

From the article "Deeper Dive—Who would buy DirecTV? " by Ben Munson.

Previously In The News

AT&T kills Plenti loyalty program but touts ongoing Thanks campaign

Parks Associates reported last year that 60% of respondents in a survey valued a rewards program for being a loyal customers, third only to the ability to roll over unused data (66%) and free access t...

One in five US subscribers now ‘dissatisfied’ with pay TV service

Some 20% of US pay TV subscribers are now dissatisfied with their pay TV service, according to research from Parks Associates. The future represents a 100% increase since 2013, according to Parks....

With 1 Gbps speeds, Verizon’s 5G fixed wireless service will leapfrog the competition

And speeds appear to matter. Parks Associates reported way back in 2015 that fully one quarter of Americans who switched to a new ISP "did so in order to obtain a faster service at a comparable price....

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...